Soligenix Stock Investor Sentiment

SNGX Stock  USD 3.35  0.02  0.60%   
Slightly above 64% of all Soligenix's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Soligenix suggests that some traders are interested. Soligenix's investing sentiment can be driven by a variety of factors including economic data, Soligenix's earnings reports, geopolitical events, and overall market trends.
  

Soligenix Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Soligenix can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
3 days ago at www.macroaxis.com         
Acquisition by Lapointe Anthony Gregg of 29126 shares of Soligenix at 1.03 subject to Rule 16b-3
Macroaxis News
few days ago at benzinga.com         
Soligenix, A Pharmaceutical Firm Tackling Potentially Lucrative Unmet Medical Needs
benzinga news
over a week ago at finance.yahoo.com         
Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma
Yahoo News
over two weeks ago at finance.yahoo.com         
Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
Yahoo News
over two weeks ago at finance.yahoo.com         
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 for the treatment of Behets Disease
Yahoo News
over two weeks ago at finance.yahoo.com         
Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels
Yahoo News
over two weeks ago at simplywall.st         
Soligenix Third Quarter 2024 Earnings US0.78 loss per share
Simply Wall St News at Macroaxis
over two weeks ago at news.google.com         
Soligenix Third Quarter 2024 Earnings US0.78 loss per share - Yahoo Finance
Google News at Macroaxis
over three weeks ago at seekingalpha.com         
Soligenix GAAP EPS of -0.78 beats by 0.61
seekingalpha News
over three weeks ago at finance.yahoo.com         
Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results
Yahoo News
over a month ago at globenewswire.com         
Soligenix, Inc. to Present at the 2024 ThinkEquity Conference
Macroaxis News: globenewswire.com
over a month ago at globenewswire.com         
Acquisition by Lapointe Anthony Gregg of 30928 shares of Soligenix at 0.97 subject to Rule 16b-3
Macroaxis News: globenewswire.com
over a month ago at finance.yahoo.com         
Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin
Yahoo News
over a month ago at www.macroaxis.com         
Acquisition by Zeldis Jerome B of 38136 shares of Soligenix at 0.59 subject to Rule 16b-3
Macroaxis News
over a month ago at finance.yahoo.com         
Soligenix Invited to Present at Upcoming Investor Conferences
Yahoo News
Far too much social signal, news, headlines, and media speculation about Soligenix that are available to investors today. That information is available publicly through Soligenix media outlets and privately through word of mouth or via Soligenix internal channels. However, regardless of the origin, that massive amount of Soligenix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Soligenix news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Soligenix relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Soligenix's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Soligenix alpha.

Soligenix Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Join Soligenixs Exclusive Live Investor Webinar and QA Session on September 18, 2024
09/16/2024
2
Soligenix enters partnership with Sterling Pharma
10/03/2024
3
HyBryte Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference
10/07/2024
4
Acquisition by Zeldis Jerome B of 38136 shares of Soligenix at 0.59 subject to Rule 16b-3
10/18/2024
5
Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin
10/22/2024
6
Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results
11/08/2024
7
Soligenix Third Quarter 2024 Earnings US0.78 loss per share
11/14/2024
8
Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
11/15/2024
9
Acquisition by Lapointe Anthony Gregg of 29126 shares of Soligenix at 1.03 subject to Rule 16b-3
11/27/2024

Additional Tools for Soligenix Stock Analysis

When running Soligenix's price analysis, check to measure Soligenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soligenix is operating at the current time. Most of Soligenix's value examination focuses on studying past and present price action to predict the probability of Soligenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soligenix's price. Additionally, you may evaluate how the addition of Soligenix to your portfolios can decrease your overall portfolio volatility.